Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06987539 |
| Consolidated Lead Sponsor | Amgen |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 15 participants (ESTIMATED) |
| Registered Start Date | 2026-07-21 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia, PA | Open Hospital Dossier -> |
| Hospital Universitari i Politecnic La Fe | Valencia, Spain | Open Hospital Dossier -> |
| John Radcliffe Hospital | Oxford, United Kingdom | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Amgen across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.